195 related articles for article (PubMed ID: 9722207)
1. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index.
Cotler SJ; Bronner MP; Press RD; Carlson TH; Perkins JD; Emond MJ; Kowdley KV
J Hepatol; 1998 Aug; 29(2):257-62. PubMed ID: 9722207
[TBL] [Abstract][Full Text] [Related]
2. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
3. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
Press RD; Flora K; Gross C; Rabkin JM; Corless CL
Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of the clinical expression of the hemochromatosis gene.
Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
[TBL] [Abstract][Full Text] [Related]
5. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.
Adams PC; Chakrabarti S
Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492
[TBL] [Abstract][Full Text] [Related]
6. [Hereditary hemochromatosis].
Dantas W
Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
[TBL] [Abstract][Full Text] [Related]
7. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
8. Update on hereditary hemochromatosis and the HFE gene.
Brandhagen DJ; Fairbanks VF; Batts KP; Thibodeau SN
Mayo Clin Proc; 1999 Sep; 74(9):917-21. PubMed ID: 10488796
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK
Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
[TBL] [Abstract][Full Text] [Related]
10. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease.
Beutler E; Felitti V; Ho NJ; Gelbart T
Acta Haematol; 2002; 107(3):145-9. PubMed ID: 11978935
[TBL] [Abstract][Full Text] [Related]
11. HFE genotype in patients with hemochromatosis and other liver diseases.
Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
13. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
14. Screening for iron overload in the Turkish population.
Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
[TBL] [Abstract][Full Text] [Related]
15. Hereditary hemochromatosis.
Crownover BK; Covey CJ
Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
17. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
[TBL] [Abstract][Full Text] [Related]
18. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S
Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
Adams PC; Reboussin DM; Leiendecker-Foster C; Moses GC; McLaren GD; McLaren CE; Dawkins FW; Kasvosve I; Acton RT; Barton JC; Zaccaro D; Harris EL; Press R; Chang H; Eckfeldt JH
Clin Chem; 2005 Jun; 51(6):1048-52. PubMed ID: 15833784
[No Abstract] [Full Text] [Related]
20. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
de Tayrac M; Roth MP; Jouanolle AM; Coppin H; le Gac G; Piperno A; Férec C; Pelucchi S; Scotet V; Bardou-Jacquet E; Ropert M; Bouvet R; Génin E; Mosser J; Deugnier Y
J Hepatol; 2015 Mar; 62(3):664-72. PubMed ID: 25457201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
